Robert Feldman
14Patents
6h-index
23Co-inventors
66Inventor score
Filing activity: Apr 25, 1991 → Apr 20, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5225331A | Immunoassay for detecting group B streptococcus | Emerging Cross-Sectional Technologies | 20 | Expired |
| US7887816B2 | Attenuated microorganisms for the treatment of infection | Emerging Cross-Sectional Technologies | 18 | Active |
| US6846667B1 | Virulence genes and proteins, and their use | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6951732B2 | Virulence genes, proteins, and their use | Human Necessities | 9 | Expired |
| US7449178B2 | Attenuated gram negative bacteria | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7211264B2 | Attenuated microorganisms for the treatment of infection | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6756042B1 | Attenuated microorganisms for the treatment of infection | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7217415B1 | NADP-dependent glyceraldehyde-3-phosphate dehydrogenase for therapeutic use | Chemistry; Metallurgy | 2 | Expired |
| US6890539B2 | Genes and proteins, and their use | Human Necessities | 2 | Expired |
| US6812021B1 | Genes and proteins and their use | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7419672B2 | Genes and proteins, and their use | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8329163B2 | Attenuated gram negative bacteria | Emerging Cross-Sectional Technologies | 1 | Active |
| US7943125B2 | Attenuated gram negative bacteria | Emerging Cross-Sectional Technologies | 1 | Active |
| US7592011B2 | Genes and proteins, and their use | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.